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Neurobiology of Disease
Mitofusin2 Mutations Disrupt Axonal Mitochondrial
Positioning and Promote Axon Degeneration
Albert L. Misko,1 Yo Sasaki,2 Elizabeth Tuck,1 Jeffrey Milbrandt,2,3 and Robert H. Baloh1,3,4
Departments of 1Neurology and 2Genetics, and 3Hope Center for Neurological Diseases, Washington University School of Medicine, St Louis, Missouri
63110, and 4Department of Neurology, Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California 90048
Alterations in mitochondrial dynamics (fission, fusion, and movement) are implicated in many neurodegenerative diseases, from rare
genetic disorders such as Charcot-Marie-Tooth disease, to common conditions includingAlzheimer’s disease. However, the relationship
between altered mitochondrial dynamics and neurodegeneration is incompletely understood. Here we show that disease associated
MFN2 proteins suppressed both mitochondrial fusion and transport, and produced classic features of segmental axonal degeneration
without cell body death, including neurofilament filled swellings, loss of calcium homeostasis, and accumulation of reactive oxygen
species. By contrast, depletion of Opa1 suppressed mitochondrial fusion while sparing transport, and did not induce axonal degenera-
tion.Axondegeneration inducedbymutantMFN2proteins correlatedwith thedisruptionof thepropermitochondrial positioningwithin
axons, rather than loss of overall mitochondrial movement, or global mitochondrial dysfunction. We also found that augmenting
expression of MFN1 rescued the axonal degeneration caused by MFN2 mutants, suggesting a possible therapeutic strategy for Charcot-
Marie-Tooth disease. These experiments provide evidence that the ability of mitochondria to sense energy requirements and localize
properly within axons is key to maintaining axonal integrity, and may be a common pathway by which disruptions in axonal transport
contribute to neurodegeneration.
Introduction
Recognizing that axons employ a non-apoptotic program of self-
destruction has been a fundamental advance in our understand-
ing of neurodegeneration, and suggests that the molecular
pathways involved could be targeted for therapeutic interven-
tion. Evidence supports that axonal degeneration precedes cell
body death in amyotrophic lateral sclerosis (Fischer and Glass,
2007), Parkinson’s disease (Cheng et al., 2010), Alzheimer’s dis-
ease (Vickers et al., 2000) and is a key factor determining mor-
bidity in multiple sclerosis (MS) and other demyelinating
diseases (Dziedzic et al., 2010). Therefore defining the mecha-
nisms underlying axonal degenerationmay be critical to prevent-
ing neurodegeneration.
Because of high-energy requirements and low intrinsic energy
reserves, neurons require continual delivery of glucose and oxy-
gen. Within minutes of onset, anoxia in optic nerve causes con-
duction block and eventually degeneration of axons (Stys et al.,
1990; Malek et al., 2005). A similar scenario of “virtual hypoxia”
instigates axonal degeneration in MS where increases in nitric
oxide (NO) levels inhibit mitochondrial respiration (Trapp and
Nave, 2008; Trapp and Stys, 2009). In peripheral nerve explants,
a transient local application of a mitochondrial membrane de-
coupler inhibitsmitochondrial respiration at the site of exposure,
and triggersWallerian degeneration of the distal axon (Alvarez et
al., 2008). Axons are thus dependent on mitochondrial produc-
tion of ATP, and even a brief failure to meet energy demands
anywhere along the axon leads to the degeneration of the entire
distal segment.
Mitochondria are actively localized to areas of high-energy
demand including the distal portion of the initial segment (Li et
al., 2004), nodes of Ranvier (Berthold et al., 1993), and presyn-
aptic boutons (Misgeld et al., 2007). These areas also experience
high Ca2 flux, which mitochondria help regulate by taking
up cytosolic Ca2 through the mitochondrial Ca2 uniporter
(Murchison and Griffith, 2007). Both ADP and Ca2 levels can
regulate mitochondrial localization (Mironov, 2007;Macaskill et
al., 2009;Wang and Schwarz, 2009). Though the continual redis-
tribution of mitochondria to maintain axonal integrity is logi-
cally implicit, it has not been experimentally demonstrated that
disruption of this system compromises axonal stability.
Mutations in Mitofusin 2 (MFN2) cause axonal Charcot-
Marie-Tooth disease, an inherited syndrome of degeneration of
long peripheral axons (Zu¨chner et al., 2004). The mutations dis-
rupt fusion (Detmer and Chan, 2007) and transport (Baloh et al.,
2007; Misko et al., 2010) of mitochondria, and also compromise
ER-mitochondrial interactions (de Brito and Scorrano, 2008).
However, how these alterations in mitochondrial dynamics pro-
duce axonal degeneration has not been defined.
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Figure1. Disruption ofmitochondrial dynamics byMFN2mutants causes selective axonal degeneration in cultured sensory neurons.A,B, Mitochondria in cultured DRGneurons expressingvirally
transducedwtMFN2 or R94Q constructs were labeledwithmito-RFP, imaged by time-lapsemicroscopy, and analyzed using kymographs. Axonalmitochondria in R94Q-expressing neurons show diminished
frequencyandspeedofmovements3dpostinfection (A,B, kymographs).Quantificationofmitochondrial flux (numberofmitochondriapassingasinglepoint) supportedadecrease in (Figure legendcontinues.)
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In this study, we investigated the relationship between altered
mitochondrial dynamics and axonal degeneration using cultured
neurons. We found that expression of MFN2 disease mutants
produced axonal degeneration without cell body death, as in pa-
tients with MFN2 mutations. By manipulating mitochondrial
fusion or transport individually, we found that axonal degenera-
tion correlated with loss of proper mitochondrial distribution in
axons, but not with loss of fusion, overall movement, or global
mitochondrial dysfunction. We therefore propose that MFN2
diseasemutants cause axonal degeneration by disrupting the abil-
ity of mitochondria to sense and position themselves appropri-
ately to meet local metabolic need within axons.
Materials andMethods
Plasmids and silencing RNAs. Human wild-type MFN2, MFN2 disease
mutants, mouse Mfn1 and opa1 siRNA constructs were previously de-
scribed (Misko et al., 2010). GFP-SYNPH was a gift from Dr. Zu-Hang
Sheng (The National Institute of Neurological Disorders and Stroke,
National Institutes of Health) and was subcloned into a lentiviral expres-
sion vector.
Dorsal root ganglion cultures. Dorsal root ganglion (DRG) cultures
were obtained from embryonic rats gestational day 15.5. Dorsal root
ganglia were dissected out, dissociate using trypsin/EDTA, and plated
directly onto 24-well plates coated with laminin and poly-D-lysine. Cul-
tures weremaintained in Neurobasal mediumwith B27 supplement (In-
vitrogen), 50 ng/ml NGF, 5 mM glutamine, and antibiotics. Addition of
5-fluorouracil for the first 3 d in culture was used as an antimitotic
treatment.
Lentivirus production and infection. Lentiviruses were produced as de-
scribed previously (Baloh, 2008). Briefly, HEK 293T cells were plated
4
(Figure legend continued.) mitochondrial mobility in R94Q-expressing neurons (number of
mitochondria/min: wtMFN2, 2.03 1.16; R94Q, 0.33 0.27; p 0.002; n 10 axons per
condition). C, Size frequency histogram demonstrating shorter mitochondrial lengths in R94Q-
expressing neurons, indicating disruption of mitochondrial fusion. D–F, Phase imaging re-
vealed dilated axon segments reminiscent of degenerating axon spheroids in neurons
expressing R94Q but not RFP or wtMFN2, 7–10 d postinfection. G–I, Staining with anti-
neurofilament antibody (NF) highlighted dilated axon segments. J–O, Degenerating segments
showed increased intra-axonal Ca 2 (Fluo-4; J, L) and markers of reactive oxygen species
[via DCFDA dye—K, M; confirmed with hydroxynonenol (HNE) immunostaining—N, O]. P,
Despite ongoing axonal degeneration, propidium iodide (PI) staining showed normal numbers
of cell bodies, indicating a selective effect of alteredmitochondrial dynamics byMFN2mutants
on axonalmaintenance. Ionomycin treatment-induced cell death is shown as a positive control
for the PI staining assay.
Figure2. Axondegeneration caused byMFN2mutant expression is segmental and dynamic.A–C, Fluo-4 imaging ofMFN2mutant-expressing axons (7 d after infection) visualized by time-lapse
microscopy (40 magnification). Axons demonstrated a rapid (minutes) elevation in intra-axonal Ca 2, followed by beading of the membrane and finally disappearing, presumably from the
inability to retain dye following loss of membrane integrity. B, These frequently appeared as short segments (50–100 m) which swelled to a spheroid like shape before completely
degenerating.C, Axonsoften lost structural integrity at a singlepoint resulting in retractionof thenends fromthebreakpoint (asterisks label endsof breakpoint).D–G, Correspondingphase contrast
and Fluo-4 images illustrate degenerating axon segments.
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onto six-well plates and transfected usingMirus reagent with a packaging
vector (8.91), envelope vector (vesicular stomatitis virus-glycoprotein),
and transfer vector encoding the gene to be expressed. Medium was
changed once at 12 h and collected at 72 h, and applied directly to DRG
cultures resulting in 95% infection efficiency.
Calcium and ROS imaging. Cell permeant Fluo-4 AM (Invitrogen) was
incubated at a final concentration of 1Mwith cultured neurons for 30min
at 37°C, washed withmedium and incubated again for 30min before imag-
ing. 5- (and-6)-Carboxy-2,7-dichlorofluorescein diacetate (carboxy-
DCFDA) was loaded at a final concentration of 1 M for 10 min at 37°C in
Neural Basal medium without B27 supplement, washed out and incubated
again for 20min before imaging. Allmicroscopy including time-lapse imag-
ingwas performedwith in a climate-controlled chamber (InVivo Scientific)
at 37°C and 5%CO2 and imageswere acquiredwith aCoolSnapHQ2CCD
camera (Photometrics) mounted on a Nikon Eclipse Ti-Umicroscope.
Measuring mitochondrial distribution and transport. Transfection of
DRG neuron cultures with mito-RFP and time-lapse imaging of mito-
chondrial movement were performed as previously described (Misko et
al., 2010). To assess mitochondrial distribution, we adapted the protocol
from (Miller and Sheetz, 2004) with minor changes. Time-lapse image
stacks of axonal mitochondria within 100 m axon segments were
used to create kymographs using MetaMorph software (Molecular De-
vices) for accurate identification of individual mitochondria. At least 10
different axons from separate neurons were imaged and divided into 10
m bins. The number of mitochondria per bin was counted and bins
were pooled for each condition. Distributions were described by com-
paring the average number of mitochondria () per bin to the variance
(var) such that var is considered uniform, var random and
var clustered. Todetermine significance levelswe used a 2 analysis of the
goodness of fit of the Poisson distribution. For each condition the
frequency distribution of bins with a certain number of mitochondria
(i  0,1, . . . 5) was determined ( fAi) and compared with the frequency
distribution predicted by the Poisson distribution ( fEi). The predicted




where P(X) is the probability of there being Xmitochondria in a bin and
 being the average number of mitochondria per bin as empirically




where n is the total number of bins counted. The  2 statistic is then
calculated by comparing the observed and predicted frequency
distributions.
2  	i  0 to i  5
	 fAi  fEi
2/fEi (3)
where i is the number of mitochondria per bin and degrees of freedom is
df 5 2 3.
Mitochondrial flux represents the average number of mitochondria
passing through the center of a bin in 1 min.
Estimating . To measure mitochondrial membrane potentials we
adopted the protocol developed by (Verburg and Hollenbeck, 2008).
Briefly, DRG cultures were incubated with 20 nM tetramethylrhodamine
methyl ester (TMRM) for 20 min at 37°C, which was then exchanged for
medium containing 5 nM TMRM in which images were acquired. A
volume corrected mitochondrial to cytoplasmic fluorescence ratio
(Fm/Fc) was calculated for at least 500 mitochondria per condition by
measuring the fluorescence of mitochondria and the fluorescence of the
immediate surrounding axoplasm and applying the formula Fm/Fc 
(Flmitochondria (2/3) Flcytoplasm)/(1/3) Flcytoplasm.
Measuring axonal mitochondrial mass. For imaging with MitoTracker
Green, cultured neurons were incubated with 75 nM MitoTracker Green
(Invitrogen) for 30 min at 37°C, washed and imaged. Labeling with
TMRM is described above. Tomeasuremitochondrial content, images of
mitochondrial fluorescence were filtered with an invertedMexican hat ker-
nel, thresholded, and the total number of pixels representing mitochondria
were counted. Phase images of corresponding areas were background sub-
tracted and thresholded and corresponding pixels representing axons were
used to normalize the mitochondrial content.
2-Deoxyglucose treatments.Medium was changed on cultures 12 h be-
fore 2DG administration to minimize fluctuations in metabolism from
week to week. 2DG was added to cultures at a final concentration of 15
mM in H2O and imaged at 48 h.
Tetrodotoxin treatment and axon degeneration measurement.DRG cul-
tures were treated with 1 M TTX on postinfection days 4–11 following
induction of mutant MFN2 constructs. Cultures were stained with
DCFDA dye as described above and imaged live on postinfection day 11.
To quantify axon degeneration, images of DCFDA fluorescence were
Figure 3. Disruption of mitochondrial fusion alone is not sufficient to induce axonal degeneration. DRG neurons were infected with lentivirus expressing siRNA to Opa1 (siOpa1) or luciferase
(control) to inhibit mitochondrial fusion, together with mito-RFP to visualize mitochondrial dynamics via live cell imaging. A–C, Knock-down of Opa1 leaves mitochondrial transport intact (A, B,
kymographs) but results in smaller fragmented mitochondria due to diminished fusion (C). Quantification of mitochondrial flux supported normal mitochondrial mobility in siOpa1-expressing
neurons (number of mitochondria/min: siLuc, 2.87 1.87; siOpa1, 2.71 1.51; p 0.828; n 10 axons per condition). Unlike expression of MFN2mutant-expressing neurons, Fluo-4 imaging
detected no signs of axonal degeneration in Opa1 deficient neurons (D,D=, E,E=).
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thresholded, and the total number of pixels, representing degenerating
axons, were determined. Phase images of corresponding areas were back-
ground subtracted, thresholded, and corresponding pixels representing
total axons were used to normalize the measure of degenerating axons.
Axonal degeneration in MFN2 mutant-expressing cultures was normal-
ized to 100% for each mutant (R94Q and H361Y), and the decrease in
axonal degeneration from TTX treatment was graphically represented as
“% control.” Therefore the control here repre-
sents the basal level of axonal seen in mutant
MFN2-expressing cultures to compare to drug
treatment.
Results
Expression of MFN2 disease mutants
causes segmental axonal degeneration
without cell body death in cultured
sensory neurons
Point mutations in MFN2 that cause in-
herited axon degeneration in humans dis-
rupt mitochondrial transport and also
alter mitochondrial fusion (Baloh et al.,
2007; Detmer and Chan, 2007; Misko et
al., 2010). However the mechanism by
which altered mitochondrial dynamics
leads to length-dependent axon degener-
ation in the peripheral nervous system re-
mains unclear. To investigate this we
introduced wild-type (wtMFN2) or dis-
ease mutant MFN2 (R94Q and H361Y)
into cultured DRG neurons using lentivi-
rus, and monitored both mitochondrial
dynamics and axonal stability. As expected,
expressionofMFN2diseasemutants altered
several aspects of mitochondrial dynamics,
dominantly inhibiting both mitochondrial
fusion andmovement within 3 d of expres-
sion, as in prior studies (Fig. 1A–C) (Misko
et al., 2010). These changes were specific to
MFN2diseasemutants, andoccurred at low
levels of lentiviral mediated MFN2 expres-
sion (1.2- to 1.4-fold above endogenous).
While disruption of mitochondrial
transport and fusion did not produce ob-
vious cell death, frequent scattered dilated
axonal segments and beading were seen
on phase contrast imaging starting at 7 d
after infection (Fig. 1F). Immunostaining
for neurofilament confirmed that numer-
ous dilated axon segments were present
in mutant (R94Q, H361Y)- but not
wtMFN2-expressing cultures, consistent
with ongoing axonal degeneration (Fig.
1G–I). Axonal degeneration is also often
accompanied by loss of Ca2 homeostasis
and accumulation of ROS (Trapp and
Stys, 2009). MFN2 mutant-expressing
cultures revealed scattered beaded and di-
lated axons intensely positive for Fluo-4
(indicating elevated Ca2 levels) and
DCFDA or HNE immunostaining (mark-
ers of ROS) (Fig. 1 J–L), providing further
support that altered mitochondrial dy-
namics produces characteristic features of
axonal degeneration in cultured neurons.
Features of axonal degeneration (swelling, beading; Fluo-4,
DCFDA, or HNE staining) were never observed in wtMFN2-
expressing cultures (Fig. 1E,G, J, J,K,N). Axonal degeneration
from mutant MFN2 expression was not a consequence of cell
body death, as cell counting revealed a similar number of cell
bodies in wtMFN2- and R94Q-expressing cultures (96.4  3%
Figure 4. MutantMFN2 andOpa1 knockdown cause similar global suppression ofmitochondrial function.A–C, TMRMdyewas
used to calculate Fm/Fc (an estimateof that corrects for cytoplasmic background) values ofmitochondria inwtMFN2 (A)-, R94Q
(B)-, and siOpa1 (C)-expressing cells. Mitochondria in siOpa1 showed a trend toward lower values, while R94Q expression did
not significantly alter  values. D, E, Despite normal levels of ATP in the cultures (D), R94Q- and siOpa1-expressing cultures
containedmore lactate in themedium, indicating a shift toward the use of glycolysis tomaintain ATP levels (E). F,G,H, Treatment
of cultureswith15mM2DG to inhibit glycolysis for 48hproducedwidespreadaxonal degeneration (as indicatedbyaxonal blebbing
seen on phase contrast images) in R94Q- and siOpa1-expressing cultures, supporting the notion that the axons aremore reliant on
glycolysis to maintain ATP levels. I, MitoTracker Green staining of R94Q- and siOpa1-expressing cultures revealed an20% and
40% decrease in mitochondrial mass, respectively.
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and 97.2  3%, respectively) after 7 d in
culture (Abhyankar et al., 2007). Likewise,
no cell death was detected using pro-
pidium iodide staining when axonal de-
generation was widespread (Fig. 1M).
These experiments confirmed that the ob-
served degeneration originated in axons
and was not a consequence of cell death.
To examine the dynamics of elevated
intra-axonal Ca2 in relation to axonal
degeneration, we performed time lapse
microscopy 7–10 d after expressing wt-
MFN2 or R94Q-MFN2 using Fluo-4 dye
(Fig. 2). Time lapse movies were taken
over 12 h, and three patterns of degenera-
tion were identified: (1) axons displaying
a normal caliber and uniform rise in intra-
cellular Ca2, followed by beading and
degeneration (seen as disappearance of
the axon after loss of membrane integrity
and inability to retain dye); (2) dilated
axon segments swelling to spheroids, fol-
lowed by loss of membrane integrity; (3)
axons breaking apart from a single point
with the ends retracting. From the onset
of increased intracellular Ca2, most ax-
ons degenerated within3 h, and no ax-
ons were observed to recover (i.e., did not
progress to blebbing and fragmentation).
Together these data indicate disrup-
tion of mitochondrial transport and fu-
sion fromMFN2mutant expression leads
to segmental loss of Ca2 homeostasis
and axonal degeneration in cultured neu-
rons without evidence of cell body death.
Axonal degeneration does not result
from loss of mitochondrial fusion or
globally decreased mitochondrial
function
Decreased levels of Opa1, a dynamin
family GTPase required for inner mito-
chondrial membrane fusion, drastically
suppresses mitochondrial fusion and pro-
duces mitochondrial dysfunction (Chen
et al., 2005), while leaving microtubule-based mitochondrial
transport intact (Misko et al., 2010). Given that MFN2 disease
mutants produce a “mixed lesion” of both mitochondrial trans-
port and mitochondrial fusion, we asked whether disruption of
mitochondrial fusion was sufficient to cause axonal degenera-
tion. Therefore we used a siRNA against Opa1 (siOpa1) to selec-
tively disrupt mitochondrial fusion without altering transport,
and looked for signs of axonal degeneration. Three days after
knockdown of Opa1, time-lapse microscopy confirmed normal
patterns of mitochondrial transport (Fig. 3A,B, kymographs),
however mitochondria were markedly smaller consistent with
suppression of fusion caused by Opa1 loss (Fig. 3C). However
despite marked suppression of mitochondrial fusion, imaging
with Fluo-4 or DCFDA dye showed no signs of axon degenera-
tion 7 d after infection (Fig. 3D–I), despite the presence of
markedmitochondrial fragmentation. These results indicate that
disruptingmitochondrial fusion alone was not sufficient to cause
axon degeneration.
Decreasedmitochondrial fusion leads to suppression ofmito-
chondrial function, including loss of membrane potential ()
and oxidative respiration (Chen et al., 2005). To interrogate mi-
tochondrial function in our cultures, we used TMRM dye to
calculate theFm/Fc value of axonalmitochondria as an estimate of
 (Verburg and Hollenbeck, 2008). One week after infection
with viral constructs, mitochondria in R94Q-MFN2-expressing
neurons maintained a Fm/Fc distribution comparable to those in
wtMFN2 controls (Fig. 4A,B), whereas mitochondria in siOpa1
infected neurons showed aminor shift in population distribution
toward lower values of Fm/Fc. (Fig. 4C). To further assess mito-
chondrial function, we looked for a shift toward anaerobic me-
tabolism bymeasuring lactate levels in the culture medium. Both
R94Q-MFN2- and siOpa1-expressing cultures contained more
lactate compared with controls, supporting a shift toward in-
creased utilization of glycolysis to maintain normal ATP levels
(Fig. 4D,E). To confirm the reliance on glycolytic production of
ATP, cultures were treated with 15 mM 2DG to inhibit glycolysis.
Figure 5. Decreasing overall mitochondrial movement alone does not cause axonal degeneration. Synph, which anchors
mitochondria to microtubules, was overexpressed by lentivirus infection and mitochondrial motility and axonal viability were
examined. A, B, Overall mitochondrial movement was dramatically reduced in Synph-overexpressing neurons (number of mito-
chondria/min: GFP, 2.71 1.23 vs Synph, 1.09 0.70, p 0.0001; n 20 axons per condition). C, A size frequency histogram
ofmitochondrial lengths demonstrated that Synph overexpression suppressedmovementwithout alteringmitochondrial fission/
fusion dynamics.D,D=, E,E=, Despite the near complete suppression ofmitochondrial movement, degenerating axons were rarely
observed in Synph-expressing cultures. Note also that despite lack of movement, the distribution of mitochondria along the axon
appeared to be preserved.
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After 48 h of treatmentwith 2DG, signs of axonal degenerationwere
apparent in both R94Q-MFN2- and siOpa1-expressing neurons,
but not wtMFN2-expressing controls. Finally, mitochondrial mass
was decreased in both R94Q- and siOpa1-expressing cells (20%
and 40% respectively; Fig. 4I), presumably reflecting the autophagic
removal ofmitochondriawithdecreasedmembranepotential (Twig
et al., 2008).
These data indicated that suppression of mitochondrial
fusion, fromeither knockdownofOpa1 orMFN2mutant expres-
sion, led to a loss of mitochondrial mass and global mitochon-
drial dysfunction in cultured neurons. However, since axonal
degeneration was not observed from knockdown of Opa1, mild
global mitochondrial dysfunction from loss of mitochondrial fu-
sion alone could not explain the segmental axonal degeneration
observed from expression of MFN2 disease mutants. As noted
above, in addition to mediating mitochondrial fusion, MFN2 is
required for mitochondrial transport via direct interactions with
the microtubule-based transport apparatus (Misko et al., 2010).
Therefore we examined the relationship between alterations in
mitochondrial transport and axonal degeneration.
Loss of proper axonal mitochondrial distribution, rather
than disruption of bulk transport, is correlated with
axonal degeneration
To define the relationship between altered mitochondrial move-
ment and axonal degeneration, we overexpressed syntaphilin
(Synph), an outer mitochondrial membrane protein which sup-
presses mitochondrial movement by anchoring mitochondria to
microtubules, but does not influence mitochondrial fusion or
interact with MFN2 (Kang et al., 2008; Misko et al., 2010). Over-
expression of Synph markedly suppressed mitochondrial move-
ment inDRGaxons by 3 d after infection, similar to that observed
by expression of MFN2 disease mutants (Fig. 5A,B) but did not
affect mitochondrial fusion (Fig. 5C). Unlike mutant MFN2 ex-
pression however, at 7–10 d after infection Synph overexpression
did not induce signs of axonal degeneration (Fig. 5D,E). This
indicated that simply blocking overall mitochondrial movement
in axons was insufficient to induce axonal degeneration. Of note,
we observed that while overall movement was suppressed in both
conditions, mitochondria in R94Q-expressing neurons fre-
quently showed clusters with large gaps between mitochondria,
which were not observed in Synph-overexpressing neurons (see
below).
In axons, mitochondria distribute to areas of high energy de-
mand where they supply ATP and buffer Ca2, functions critical
to axonal integrity (for review, see Baloh, 2008). In culturedDRG
neurons,mitochondria distribute uniformly along axons, consis-
tent with their ability to sense energy requirements and position
where they are needed (Miller and Sheetz, 2004).MFN2 interacts
directly withMiro1 andMiro2, OMMproteins which function as
Ca2 sensors to regulate mitochondrial localization to sites of
high Ca2 (Saotome et al., 2008;Macaskill et al., 2009;Wang and
Schwarz, 2009; Misko et al., 2010). Therefore we investigated
whether MFN2 mutants disrupt the ability of mitochondria to
sense energy demand and properly distribute in axons, which
would compromise axonal integrity.
Mitochondria in DRG neurons infected with wtMFN2,
R94Q-MFN2, Synph, or siOpa1 constructs were labeled with
mito-RFP and imaged by time-lapse microscopy. Kymographs
were used to identify stationary mitochondria, represented as
black dots underneath kymographs (Fig. 6).While themitochon-
drial distribution in wtMFN2-, Synph-, or siOpa1-expressing
cells appeared uniform (Fig. 6A,C), axon segments in R94Q-
expressing cells were often devoid of mitochondria (Fig. 6B, ar-
rowhead). To quantitate mitochondrial distribution, we used a
previously described statisticalmethod thatwas used to show that
mitochondria are uniformly distributed in axons of cultured
DRGneurons (Miller and Sheetz, 2004). Axons were divided into
10mbins andmitochondria were counted in at least 10 bins per
axon across 10 different axons. A mitochondrial population was
considered uniformly distributed if the average number of mito-
chondria per bin () was greater than the variance (var), random
if  var and clustered if  var. By this measure, mitochon-
dria were uniformly distributed in cells expressing wtMFN2,
Synph, or siOpa1, but randomly distributed in R94Q-expressing
cells (Table 1). Comparing observed distributions to the Poisson
distribution with the samemean by using a 2 goodness of fit test
confirmed that mitochondrial distributions in wtMFN2, Synph,
and siOpa1 axons differed significantly from the Poisson distri-
bution (p 0.001) (i.e., were evenly distributed) while the pop-
Figure 6. Abnormal distribution of axonal mitochondria correlates with axonal degenera-
tion from mutant MFN2 expression. Mitochondria in cultured DRG neurons expressing virally
transduced wtMFN2, R94Q, siOpa1 or Synph were labeled with mito-RFP and imaged by time-
lapse microscopy 1 week after infection. A–D, Kymographs were used to assist in the identifi-
cation of fluorescently labeled mitochondria. Individual mitochondria are represented as black
dots below kymographs.Whilemitochondriawere evenly distributed along axons ofwtMFN2-,
Synph-, and siOpa1-expressing neurons (A, C, D), R94Q mutant-expressing axons commonly
displayed prolonged segments that were devoid of mitochondria (B, arrowhead). Axons from
10 neuronswere divided into 10mbins (length of bracket in A) and the number ofmitochon-
dria counted per bin. Mitochondrial distributions were compared with a Poisson distribution
with a 2 goodness of fit test as described in the text and shown in Table 1.
Table 1. Mitochondrial distribution in axons
wtMFN2 R94Q siOpa1 GFP Synph
Average number of mitochondria/bin 2.1 1.52 1.98 1.24 1.93
Variance 1.14 1.52 1.37 0.41 0.65
c 2 19.89 4.99 18.16 50.05 73.79
p-value 0.001 0.0288 0.001 0.001 0.001
Bold p-value, Not significantly different from the Poisson distribution ( p 0.001).
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ulation in R94Q-expressing neurons did
not (p 0.0288) (i.e., were unevenly dis-
tributed) (Table 1).
These data support that altered axonal
mitochondrial distribution, rather than loss
of overall mitochondrial movement per se,
is responsible for axonal degeneration in
mutantMFN2-expressing cultures.
Sodium channel blockade, andMfn1
overexpression can prevent axonal
degeneration inMFN2 disease
mutant-expressing cells
The findings above suggest that the seg-
mental degeneration observed in axons
expressing MFN2 mutants occurs at local
regions devoid of mitochondria, which
are functionally “hypoxic.” The cascade of
molecular events perpetuating the degen-
eration of hypoxic axons has been well
characterized (Stirling and Stys, 2010).
Energy deficits in an axon lead to failure of
the Na-K pump, which allows Na to
accumulate in the cytoplasm. This forces
theNa-Ca2 exchanger to reverse direc-
tions and triggers an influx of Ca2 that
elicits the final stages of axon degenera-
tion (Stys et al., 1992). In experimental
hypoxia paradigms, addition of TTX to rat
optic nerve obstructs influx of extracellular
Na and prevents downstream degenera-
tion (Wolf et al., 2001). We reasoned that if
the abnormal distribution of mitochondria
in MFN2 mutant-expressing neurons left
axonal segments devoid of mitochondria in
a state of virtual hypoxia, then treatment of
these cultureswithTTXwouldprevent their
degeneration. Therefore we treated mutant
MFN2-expressing DRG cultures with TTX,
and cultures were imaged at 7 d later with
DCFDAdye to visualize segmental axonde-
generation (Fig. 7A–D). Treatment with
TTX markedly decreased the number of DCFDA-positive axons in
mutant-expressing cultures (Fig. 7E). These data support that local
loss of mitochondrial function leads to “virtual hypoxia” and seg-
mental axon degeneration, and that blocking the influx of Na via
TTX can prevent the cascade of axonal degeneration similar to the
protection observed in experimentally hypoxic axons.
We recently showed that increased expression of Mfn1 in cul-
tured neurons could restore normal axonal transport of mito-
chondria in Mfn2-null DRG neurons, as basal levels of Mfn1 is
low in these neurons relative to non-neuronal cells (Misko et al.,
2010). Furthermore, another study found that expression of
Mfn1 could also complement the fusion defect induced by some
MFN2 disease mutants (Detmer and Chan, 2007). Therefore, to
investigate augmentation of Mfn1 expression as a potential ther-
apeutic strategy for CMT2A, we examined whether expression of
exogenous Mfn1 could prevent the axon degeneration observed
in cultures expressing the R94Q MFN2 mutant. Neurons were
first infected with lentivirus containing an R94Q construct, and
subsequently a second lentivirus containing a Mfn1 construct.
When cultures were imaged with Fluo-4 dye 1 week later, signs of
axonal degeneration were completely absent (Fig. 8A–D). Intro-
duction ofMfn1 rescuedmitochondrial transport and content in
axons, indicating that increased expression of Mfn1 above en-
dogenous levels is able to overcome the dominant effect of the
MFN2 R94Q mutant on mitochondrial dynamics (Fig. 8E,F).
These data indicate that augmenting levels of Mfn1 in the ner-
vous system of CMT2A patients may offer a viable strategy for
therapeutics development.
Discussion
These experiments demonstrate that MFN2 mutant proteins al-
termitochondrial dynamics and trigger segmental axon degener-
ation in cultured neurons. AlthoughMFN2mutants altered both
the overall movement and fusion of mitochondria, by compari-
son to other interventions (blocking fusion with Opa1 knock-
down, or bulk movement with Synph overexpression), the key
abnormality produced by MFN2 mutants that correlated with
axonal degeneration was the alteration of proper distribution of
mitochondria along axons. This suggests that MFN2 mutants
disrupt the sensingmechanisms based at the outermitochondrial
membrane that organize mitochondrial position within axons,
consistent with their interactions with components of the Miro–
Figure 7. TTX treatment diminishes axonal degeneration in cultured DRG neurons expressing MFN2 disease mutants. DRG
cultures expressing the R94Q or H361Y MFN2 disease mutants to induce axon degeneration were treated with 1M TTX on DIV4
through DIV11. A–D, DCFDA imaging after 1 week of treatment showed amarked decrease in the number of degenerating axons
(A, C). Fluorescence images were converted into binary format (B, D) and degenerating axons were measured as DCFDA pixels
per field. E, DRG neurons expressing MFN2 mutants treated with TTX showed a significant decrease in the number of DCFDA-
positive degenerating axons 1week after infectionwith R94Q or H361Y viral constructs (TTX treatment vs untreated control, *p
0.01, Student’s t test). Control in this experiment refers to MFN2mutant-expressing cultures, comparedwith treatment with TTX.
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Milton-Kinesin system. This segmental “virtual hypoxia” as the
driver of degeneration inmutantMFN2-expressing cells was sup-
ported by the ability of TTX to prevent axonal degeneration,
similar to other models of hypoxic axonal injury. These data
therefore provide a direct link between altered mitochondrial
dynamics and axonal degeneration, and specifically point to dis-
ruption of local axonal mitochondrial energy sensing and posi-
tioning as a key factor. As altered axonal transport is a common
feature of most neurodegenerative and demyelinating diseases,
the disruption of local mitochondrial distribution within axons
may be a key step leading to axon degeneration in a diverse set of
diseases beyond CMT2A.
Mitochondrial function in the maintenance of axon integrity
The conduction of action potentials along nerves and white mat-
ter tracks is costly, requiring energy to pump ions across the
plasmamembrane and establish the restingmembrane potential.
Despite the high demands of action potential propagation, neu-
rons have low intrinsic energy reservoirs and require a continu-
ous supply of oxygen and glucose. Disruption of energy
production in axons initiates a series of events leading to axonal
degeneration: (1) failure of theNa-K pump from lack of ATP;
(2) Na accumulation through persistent Na channels and K
efflux; and (3) reversal of the Na-Ca2 exchanger driven by
high axoplasmic Na and consequent accumulation of intracel-
lular Ca2 (Stys et al., 1992).High intra-axonal Ca2marks a late
stage in axon degeneration leading to the
activation of calpains, and degradation of
the neurofilament network (Trapp and
Nave, 2008). Even a transient local deficit
in mitochondrial metabolism can be suf-
ficient to trigger axonal degeneration. Ex-
perimental exposure of peripheral nerves
to NO, which inhibits mitochondrial res-
piration, initiatesWallerian degeneration
that spreads distal to the administration
site, even when the NO is removed within
3 h of exposure. The same effects are seen
with a brief administration of DNP, an
uncoupler of mitochondrial respiration
(Alvarez et al., 2008). Similar local deficits
are likely to arise when disruption of mi-
tochondrial transport leaves segments of
axon devoid of mitochondria, creating a
state of local “virtual hypoxia.” Our data
suggest that this mechanism may be the
inciting cause of axon degeneration in
CMT2A.
The importance of mitochondrial en-
ergy sensing and proper movement is also
relevant to other neurodegenerative dis-
eases. In demyelinating disorders such as
MS, mitochondria accumulate at de-
nuded axon segments, presumably to
meet the increased energy demands of ac-
tion potential propagation (Andrews et
al., 2006; Hogan et al., 2009; Witte et al.,
2009). In damaged axons in brains of hu-
mans with multiple sclerosis and of mice
with cuprizone-induced demyelination,
elevated levels of cytosolic HDAC1 were
shown to directly inhibit mitochondrial
transport (Kim et al., 2010). The increased
need for mitochondria at denuded axon segments suggests that
secondary axonal injury would be increased if mitochondrial
transport was disrupted. Developing drugs to enhance the effi-
cacy of proper mitochondrial transport and localizationmay im-
prove the survival of demyelinated axons by increasing their
mitochondrial reserves.
Disrupted mitochondrial transport has also been implicated
in numerous neurodegenerative diseases including Alzheimer’s
disease, Huntington’s disease, amyotrophic lateral sclerosis and
others (Morfini et al., 2009). Though the mechanism by which
axonal transport is disrupted is likely different in the various
neurodegenerative diseases, altered mitochondrial transport and
localization may be a key and early event, which drives axonal
degeneration similar to that observed from expression of MFN2
disease mutants.
The connection between segmental energy crisis and
length-dependent axon degeneration
A striking feature of CMT2A is the predilection for degeneration
of peripheral sensory andmotor neuronswith long axons, despite
the ubiquitous expression of MFN2 in all cells. It is reasonable to
consider that long axons may be more susceptible to deficits in
mitochondrial transport based on their length for several reasons.
First, abnormal transport could significantly delay or even pre-
vent the migration of newly synthesized mitochondria in the cell
body from reaching the most distal axon segments. However it is
Figure8. ExpressionofMfn1 rescues axonal degeneration inducedbyMFN2diseasemutants.A–D, CulturedDRGneuronswere
infected with R94Q mutant MFN2 on DIV3, and subsequently infected with control or Mfn1 constructs on DIV4. Whereas Fluo-4
imaging showed frequent degenerating axons in cultured neurons expressing R94Q-MFN2 as before, cultures coinfected with
Mfn1 and R94Q-MFN2 showed no signs of axonal degeneration 7 d after infection. E, F, Expression of Mfn1 rescuedmitochondrial
transport, asmeasured both by the amount ofmitochondriamigrating into axons after infectionwithmito-DsRed2 virus (E; *p
0.001, Student’s t test), and frequency of mitochondrial movement measured as mitochondria/per minute crossing an arbitrary
point along the axon (F; *p 0.001, Student’s t test).
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notable from several studies of patient biopsies that diminished
mitochondrial populations are not evident in sural nerves from
CMT2A patients, and instead clusters of small mitochondrial are
frequently seen in distal axons (Verhoeven et al., 2006; Vallat et
al., 2008). There is also evidence that mitochondrial biogenesis
may take place in axons negating the dependency on transport of
mitochondria from the soma (Amiri and Hollenbeck, 2008; Vin-
cent et al., 2010). The data shown here support that a deficit in
regulation of local (rather than long range) transport and distri-
bution ofmitochondria to regions of energy demand along axons
would compromise axon integrity and drive axonal degenera-
tion. Assuming random fluctuations in ATP and Ca2 levels oc-
cur at some frequency per a given length of axon, then longer
axons would encounter these events more frequently. Therefore
an overall compromise in the ability of mitochondria to move to
these sites and restore Ca2 homeostasis would still lead to pref-
erential degeneration of the longest axons. Indeed, biopsies from
patients withMFN2mutations have frequently shown clustering
of small round mitochondria within axons, consistent with the
observed alterations in mitochondrial distribution observed in
our culture system (Verhoeven et al., 2006; Vallat et al., 2008;
Calvo et al., 2009).
Another potential connection between MFN2 mutants and
intra-axonal Ca2 homeostasis would be the role for MFN2 as a
tether between mitochondria and the ER. de Brito and Scorrano
(2008) reported that ER morphology was abnormal in Mfn2/
MEFs lacking endogenous Mfn2, and that R94Q mutant MFN2
was not able to rescue the ER defect. Here we modeled the effects
of R94QmutantMFN2 in cells with normal levels of endogenous
Mfn2, to mimic the dominant effect of these mutants seen in
CMT2A patients. Unfortunately we were not able to obtain suf-
ficient material from DRG neurons to directly measure ER-
mitochondrial tethering biochemically. However, since Mfn1
expression was able to rescue Ca2 homeostasis and axonal de-
generation induced by MFN2 mutants, this argues that in our
culture system MFN2 mutants do not promote axonal degener-
ation by disrupting ER-mitochondrial tethering and Ca2 buff-
ering, becauseMfn1 does not rescue ER-mitochondrial tethering
(de Brito and Scorrano, 2008). By contrast, Mfn1 is able to rescue
the mitochondrial transport abnormalities seen in Mfn2/
DRGneurons (Misko et al., 2010), supporting it is the recovery of
normal mitochondrial transport and localization that mediates
the protective effect of Mfn1 overexpression in MFN2 mutant-
expressing neurons.
ModulatingMfn1 expression as a neuroprotective strategy in
the treatment of CMT2A
It is also possible that the lower level of Mfn1 expression relative
to other cell types contributes to the sensitivity of peripheral neu-
rons to MFN2 mutations (Detmer and Chan, 2007), in addition
to their requirement for carefully regulated mitochondrial trans-
port. We previously reported that levels of Mfn1 protein in DRG
neurons were somewhat lower than mouse embryonic fibro-
blasts, and observed a different migration pattern on Western
blotting (Misko et al., 2010). Furthermore we found here that
augmenting Mfn1 levels via lentiviral expression was able to res-
cue faulty axonal transport and the axonal degeneration pro-
duced by MFN2 mutant expression. Though it is hard to know
what levels of Mfn1 would be required to provide a similar com-
pensatory recovery in patients, efforts toward understanding
transcriptional and translational regulation of Mfn1 in neurons
to augment its expression could be a useful strategy toward de-
veloping therapeutic agents for CMT2A.
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